Evidence map›Paper›PMID 36989360›Full record

ArticleScience advances2023

Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation.

Pratyusha Bala, Jonathan P Rennhack, Daulet Aitymbayev, Clare Morris, Sydney M Moyer, Gina N Duronio, Paul Doan, Zhixin Li, Xiaoyan Liang, Jason L Hornick and 3 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 53 citations in OpenAlex.

  1. Single-cell epigenomics of colorectal cancer.Experimental & molecular medicine · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Diet-induced chromatin states influence intestinal stem cell memory.bioRxiv : the preprint server for biology · 2026
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Pratyusha BalaDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0001-7686-4700
Jonathan P RennhackDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0001-6306-195X
Daulet AitymbayevDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0001-7277-2884
Clare MorrisDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0003-0375-2446
Sydney M MoyerDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0002-2911-4058
Gina N DuronioDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Paul DoanDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Zhixin LiDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0001-9962-3942
Xiaoyan LiangDepartment of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.ORCID 0000-0002-2099-7253
Jason L HornickDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-6475-8345
Matthew B YurgelunDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0002-6184-9273
William C HahnDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0003-2840-9791
Nilay S SethiDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0002-3748-7559
Broad Institute · USDana-Farber Cancer Institute · USBrigham and Women's Hospital · USThe Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI JENNIFER W MACK · 1985 to 2026
$330.6M
STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JONATHAN C KAGAN · 1986 to 2026
$32.4M
Integration of early genetic alterations and inflammation in gastroesophageal premalignancyK08DK120930 · NIDDK · DANA-FARBER CANCER INST · PI SETHI, NILAY · 2019 to 2023
$790k
The Role of E2F2 in HER2 Positive Breast CancerK00CA212221 · NCI · DANA-FARBER CANCER INST · PI RENNHACK, JONATHAN · 2018 to 2021
$366k
NCI NIH HHS K00 CA212221NCI NIH HHS P30 CA006516NIDDK NIH HHS K08 DK120930NIDDK NIH HHS P30 DK034854
6 · The paper itself

Abstract

Cell state plasticity is carefully regulated in adult epithelia to prevent cancer. The aberrant expansion of the normally restricted capability for cell state plasticity in neoplasia is poorly defined. Using genetically engineered and carcinogen-induced mouse models of intestinal neoplasia, we observed that impaired differentiation is a conserved event preceding cancer development. Single-cell RNA sequencing (scRNA-seq) of premalignant lesions from mouse models and a patient with hereditary polyposis revealed that cancer initiates by adopting an aberrant transcriptional state characterized by regenerative activity, marked by

Indexed as

AdenomaColorectal NeoplasmsAnimalsCell DifferentiationIntestinesMice

Identifiers

PMID36989360
PMCPMC10058311
OpenAlexW4361305319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.